The Evicel Post-Authorization Surveillance Study

CompletedOBSERVATIONAL
Enrollment

300

Participants

Timeline

Start Date

June 30, 2010

Primary Completion Date

April 30, 2014

Study Completion Date

May 31, 2014

Conditions
Peripheral Vascular DiseaseHemorrhage
Interventions
BIOLOGICAL

EVICEL ™ Fibrin Sealant (Human)

Commercial Evicel

Trial Locations (2)

32207

Baptist Health Medical Center, Jacksonville

32216

Memorial Hospital, Jacksonville

Sponsors

Collaborators (1)

All Listed Sponsors
collaborator

OMRIX Biopharmaceuticals

INDUSTRY

lead

Ethicon, Inc.

INDUSTRY

NCT01158261 - The Evicel Post-Authorization Surveillance Study | Biotech Hunter | Biotech Hunter